En español
NIDA

Treatment Research

Treatment Statistics

According to the Substance Abuse and Mental Health Services Administration’s (SAMHSA’s) National Survey on Drug Use and Health,1 23.5 million persons aged 12 or older needed treatment for an illicit drug or alcohol abuse problem in 2009 (9.3 percent of persons aged 12 or older). Of these, only 2.6 million—11.2 percent of those who needed treatment—received it at a specialty facility.

Treatment Approaches for Drug Addiction

NOTE: This is a fact sheet covering research findings on effective treatment approaches for drug abuse and addiction. If you are seeking treatment, please call the Substance Abuse and Mental Health Services Administration's (SAMHSA) National Drug and Alcohol Treatment Service at 1–800–662–HELP (4357) for information on hotlines, counseling services, or treatment options in your State. Drug treatment programs by State also may be found online at www.findtreatment.samhsa.gov.

Drug-Related Hospital Emergency Room Visits

National estimates on drug-related visits to hospital emergency departments (ED) are obtained from the Drug Abuse Warning Network (DAWN),1,2 a public health surveillance system managed by the Substance Abuse and Mental Health Services Administration (SAMHSA), U.S. Department of Health and Human Services (HHS). DAWN data* are based on a national sample of general, non-Federal hospitals operating 24-hour Emergency Departments (EDs).

New Approach Uses Immune Cells To Deliver Anti-HIV Medications

Nano-antiretroviral therapy (nano-ART) turns macrophages—one of the very cell types that HIV uses to replicate and spread through the body—into carriers for anti-HIV medications. The approach has the potential to make treatment for HIV easier and more effective.

Training Workshops Boost Approval of Contingency Management

Clinicians associated with the Veterans Administration looked more favorably upon contingency management after attending training workshops on the use of the intervention. Despite being highly effective at decreasing drug use, contingency management is one of the least used among proven substance abuse treatments.

New brain imaging dataset now available to enhance reliability and reproducibility

A new NIDA-supported dataset will now allow researchers to compare their MRI-based scans against more than 10,000 brain images, thereby enhancing reliability and reproducibility.


Gene Variants Reduce Opioid Risks

Two recent studies suggest that genotyping may enable clinicians to base therapies on individual patients’ potential responsiveness to opioid drugs’ therapeutic effects and vulnerability to their harmful effects.

National Longitudinal Study of the Neurodevelopmental Consequences of Substance Use

Photo of a group of teens

By Nora Volkow (Director, NIDA), George Koob (Director, NIAAA), Alan Guttmacher (Director, NICHD), and Bob Croyle (Director, Divison of Cancer Control and Population Sciences, NCI)

Dr. Joni Rutter Q&A: How Basic Science Is Tackling Addiction

One of NIDA’s goals is to try to understand the individual differences that contribute to whether or not someone who takes a drug will become addicted to it. Dr. Rutter’s research focuses on three types of differences: Environmental, developmental, and genetic and epigenetic.

Pages

Subscribe to Treatment Research